Exane Derivatives’s Trustco Bank Corp NY TRST Stock Holding History

Exane Derivatives’s Portfolio TRST Stock Details TRST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,425	Closed	-$221K	–	709
2019 Q3	$221K	Sell	5,425 -958	-15%	-$38K	0.04%	238
2019 Q2	$253K	Buy	+6,383	New	+$248K	0.04%	238

Other funds holding TRST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Exane Derivatives's TRST Position: Q4 2019 in Review

Exane Derivatives sold out of Trustco Bank Corp NY (TRST) in Q4 2019, closing a stake of 5,425 shares — an estimated $221K sold.

Exane Derivatives first reported a position in TRST in Q2 2019 and held it in 2 quarters. The position peaked at $253K in Q2 2019. 177 funds tracked by Wall St. Rank hold TRST as of Q4 2019.

Exane Derivatives reported no remaining Trustco Bank Corp NY position as of Q4 2019 after selling out during the quarter.
Exane Derivatives sold 5,425 Trustco Bank Corp NY shares in Q4 2019, an estimated $221K.
Exane Derivatives first reported a position in Trustco Bank Corp NY in Q2 2019 and held it in 2 quarters.
Exane Derivatives's Trustco Bank Corp NY position peaked at $253K in Q2 2019.
177 funds tracked by Wall St. Rank held Trustco Bank Corp NY as of Q4 2019.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.